Fresenius SE & Co. (OTCMKTS:FSNUY) Shares Gap Up – Here’s Why

Posted by Micah Haroldson on Jun 30th, 2026

Fresenius SE & Co. (OTCMKTS:FSNUY – Get Free Report) shares gapped up prior to trading on Tuesday . The stock had previously closed at $11.37, but opened at $11.84. Fresenius SE & Co. shares last traded at $11.2950, with a volume of 11,915 shares trading hands.

Analyst Upgrades and Downgrades

Separately, Morgan Stanley reiterated an “overweight” rating on shares of Fresenius SE & Co. in a research report on Tuesday, June 23rd. Three equities research analysts have rated the stock with a Buy rating, Based on data from MarketBeat, the stock currently has an average rating of “Buy”.

Check Out Our Latest Analysis on FSNUY

Fresenius SE & Co. Stock Up 1.4%

The company has a debt-to-equity ratio of 0.41, a current ratio of 1.27 and a quick ratio of 0.98. The firm has a market cap of $25.97 billion, a price-to-earnings ratio of 15.37 and a beta of 0.64. The firm has a 50 day moving average price of $11.47 and a 200-day moving average price of $13.14.

Fresenius SE & Co. (OTCMKTS:FSNUY – Get Free Report) last posted its quarterly earnings results on Wednesday, May 6th. The company reported $0.24 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.25 by ($0.01). The firm had revenue of $6.75 billion during the quarter, compared to the consensus estimate of $6.79 billion. Fresenius SE & Co. had a net margin of 6.55% and a return on equity of 10.09%. As a group, equities analysts predict that Fresenius SE & Co. will post 1.03 EPS for the current fiscal year.

Fresenius SE & Co. Company Profile

(Get Free Report)

Fresenius SE & Co KGaA is a global healthcare group headquartered in Bad Homburg vor der Höhe, Germany. Founded in 1912 by Eduard Fresenius, the company has grown into one of the world’s leading providers of products and services for dialysis, hospitals and outpatient medical care. Trading on major European exchanges and available over the counter in the U.S. as FSNUY, Fresenius SE & Co brings together a portfolio of specialized healthcare businesses under one corporate umbrella.

The company operates through four main business segments.